The U.S. Centers for Disease Control and Prevention and the Food and Drug Administration said Tuesday they are recommending a “pause” in the use of the single-dose Johnson & Johnson COVID-19 vaccine out of an “abundance of caution” while an investigation is conducted into reports of apparently rare, potentially dangerous blood clots.
Due to a subsequent directive by the Te...
To access content, please login or purchase a subscription.